Stockreport

European Patent Office Grants New Patent Covering Enlivex’s Allocetra™ Immunotherapy Treatment

Enlivex Therapeutics Ltd. - Ordinary Shares  (ENLV) 
PDF Nes-Ziona, Israel, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced that the European Patent Offic [Read more]